The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...
MedPage Today on MSN
New FDA-Approved Option for HER2-Mutated Lung Cancer
The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).
Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.
The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...
New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...
FOX 5 Atlanta on MSN
Hoschton woman defies odds, survives stage 4 lung cancer diagnosis
Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...
16h
If you experience these symptoms repeatedly, you could have lung cancer: “You should see a doctor”
A health campaign urges the public to pay closer attention to subtle warning signs that often go unnoticed in the earliest ...
Tumor infiltrating lymphocyte (TIL) therapy uses immune cells harvested directly from a patient’s tumor.
New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...
Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...
Nearly 8% of Ohioans live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Ohio is among the states in the country ...
The FDA has approved Hyrnuo for some with locally advanced or metastatic non-squamous non–small cell lung cancer with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback